STERIS plc (STE)

Currency in USD
247.35
+3.54(+1.45%)
Real-time Data·
STE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
240.82249.68
52 wk Range
204.90269.44
Key Statistics
Prev. Close
243.81
Open
246.47
Day's Range
240.82-249.68
52 wk Range
204.9-269.44
Volume
454.73K
Average Volume (3m)
659.94K
1-Year Change
9.7188%
Book Value / Share
73.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
281.63
Upside
+13.86%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 15 consecutive years

STERIS plc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

STERIS plc Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

STERIS plc SWOT Analysis


Infection Prevention Leade
STERIS plc, a key player in healthcare infection prevention, showcases consistent growth and financial stability in a critical market secto
Financial Resilience
Explore STERIS's track record of mid-single-digit sales growth and double-digit EPS growth, with analyst price targets ranging from $265 to $280
Market Positioning
Delve into STERIS's premium valuation, driven by its non-elective product portfolio and strong execution in the healthcare and life sciences industries
Challenges Ahead
Learn about STERIS's strategies to navigate ongoing EtO litigation, rising input costs, and evolving regulatory environments while maintaining market leadership
Read full SWOT analysis

STERIS plc Earnings Call Summary for Q2/2026

  • STERIS reported Q2 FY2025 adjusted EPS of $2.47 (15% YoY increase), beating forecasts of $2.36, while revenue missed at $1.03B versus expected $1.43B, yet shares rose 7.42% to $243.18.
  • The company raised full-year EPS guidance to $10.15-$10.30 and expects revenue growth of 8-9%, with healthcare showing strong performance across all categories.
  • Financial highlights include a 60 basis point improvement in gross margin to 44.3% and a 90 basis point increase in EBIT margin to 23.1%, despite tariff impacts.
  • Healthcare capital equipment backlog exceeded $400M, while free cash flow reached $527.7M for H1 FY2026, prompting an increased annual free cash flow outlook to $850M.
  • CEO Dan Carestio cited strength in healthcare procedures and bioprocessing recovery as key growth drivers, expressing confidence in meeting revised expectations.
Last Updated: 2025/11/06, 17:56
Read Full Transcript

Compare STE to Peers and Sector

Metrics to compare
STE
Peers
Sector
Relationship
P/E Ratio
34.1x26.5x−0.5x
PEG Ratio
0.660.600.00
Price/Book
3.4x2.4x2.6x
Price / LTM Sales
4.1x2.3x3.3x
Upside (Analyst Target)
18.7%16.5%48.1%
Fair Value Upside
Unlock20.7%7.7%Unlock

Analyst Ratings

6 Buy
2 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 281.63
(+13.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold256.00+2.84%-MaintainFeb 05, 2026
Citizens
Buy280.00+12.49%-MaintainFeb 05, 2026
Citizens
Buy280.00+12.49%-MaintainFeb 04, 2026
Jefferies
Sell256.00+2.84%250.00MaintainNov 10, 2025
Needham
Hold---MaintainNov 06, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.20%
Dividend Yield
1.03%
Industry Median 1.36%
Annualised payout
2.52
Paid quarterly
5-Years Growth
+9.28%
Growth Streak

Earnings

Latest Release
Feb 04, 2026
EPS / Forecast
2.53 / 2.53
Revenue / Forecast
1.50B / 1.48B
EPS Revisions
Last 90 days

STE Income Statement

FAQ

What Is the STERIS (STE) Stock Price Today?

The STERIS stock price today is 247,35

What Stock Exchange Does STERIS Trade On?

STERIS is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for STERIS?

The stock symbol for STERIS is "STE."

Does STERIS Pay Dividends? What’s The Current Dividend Yield?

The STERIS dividend yield is 1.03%.

What Is the STERIS Market Cap?

As of today, STERIS market cap is 24.40B.

What Is STERIS's Earnings Per Share (TTM)?

The STERIS EPS (TTM) is 7.20.

When Is the Next STERIS Earnings Date?

STERIS will release its next earnings report on 19 May 2026.

From a Technical Analysis Perspective, Is STE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has STERIS Stock Split?

STERIS has split 2 times.

How Many Employees Does STERIS Have?

STERIS has 17787 employees.

What is the current trading status of STERIS (STE)?

As of 06 Feb 2026, STERIS (STE) is trading at a price of 247,35, with a previous close of 243,81. The stock has fluctuated within a day range of 240,82 to 249,68, while its 52-week range spans from 204,90 to 269,44.

What Is STERIS (STE) Price Target According to Analysts?

The average 12-month price target for STERIS is USD281,63, with a high estimate of USD300 and a low estimate of USD231. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +13,86% Upside potential.

What Is the STE Premarket Price?

STE's last pre-market stock price is 242,77. The pre-market share volume is 69,00, and the stock has decreased by -1,04, or -0,43%.

What Is the STE After Hours Price?

STE's last after hours stock price is 243,77, the stock has decreased by -0,04, or -0,02%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.